The Health Economics Methods Advisory (HEMA) group has been convened by the leaders of three HTA organizations to critically and independently examine and assess new methods and processes:
- The USA-based Institute for Clinical and Economic Review (ICER);
- Canada’s Drug Agency (CDA-AMC);
- England’s National Institute for Health and Care Excellence (NICE).
ICER’s Chief Scientific Officer and Director of Health Technology Assessment Methods and Engagement Dan Ollendorf, PhD, MPH will coordinate this effort in partnership with leaders at NICE and CDA.
HEMA Secretariat
